Metagenomics Market Size, Share & Trends Report

Metagenomics Market Size, Share & Trends Analysis Report By Technology (Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing), By Product, By Workflow, By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-2-68038-452-9
  • Number of Pages: 115
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1. Metagenomics Market: Methodology and Scope
                   1.1. Market Segmentation and Scope
                   1.2. Market Definitions
                       1.2.1. Information analysis
                       1.2.2. Market formulation & data visualization
                       1.2.3. Data validation & publishing
                   1.3. Research Assumptions
                   1.4. Information Procurement
                       1.4.1. Primary Research
                   1.5. Information or Data Analysis
                   1.6. Market Formulation & Validation
                   1.7. Market Model
                   1.8. Global Market: CAGR Calculation
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Metagenomics Market: Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Metagenomics Market: Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Trends and Outlook
                   3.3. Market Dynamics
                       3.3.1. Declining expenses of sequencing
                       3.3.2. Developments in biotechnology & bioinformatics techniques
                       3.3.3. Rising interest in microbial screening for different investigations
                       3.3.4. Emergence of new fields in genomics that complement metagenomics
                   3.4. Market Restraint Analysis
                       3.4.1. Limited accessibility to computation and different analytic tools
                       3.4.2. High overall cost of metagenomics
                   3.5. Business Environment Analysis
                       3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
                       3.5.2. Porter’s Five Forces Analysis
                   3.6. COVID - 19 Impact Analysis
Chapter 4. Technology Business Analysis
                   4.1. Metagenomics market: Technology Movement Analysis
                   4.2. Shotgun Sequencing
                       4.2.1. Shotgun Sequencing Market, 2018 - 2030 (USD Million)
                   4.3. 16S Sequencing
                       4.3.1. 16S Sequencing Market, 2018 - 2030 (USD Million)
                   4.4. Whole Genome Sequencing
                       4.4.1. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
                   4.5. Others
                       4.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Product Business Analysis
                   5.1. Metagenomics market: Product Movement Analysis
                   5.2. Kits and Reagents
                       5.2.1. Kits and Reagents Market, 2018 - 2030 (USD Million)
                   5.3. Sequencing & Data Analytics Services
                       5.3.1. Sequencing & Data Analytics Services Market, 2018 - 2030 (USD Million)
                   5.4. Software
                       5.4.1. Software Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
                   6.1. Metagenomics market: Application Movement Analysis
                   6.2. Environmental Application
                       6.2.1. Environmental Application Market, 2018 - 2030 (USD Million)
                   6.3. Clinical Diagnostics Applications
                       6.3.1. Clinical Diagnostics Applications Market, 2018 - 2030 (USD Million)
                   6.4. Drug Discovery Applications
                       6.4.1. Drug Discovery Applications Market, 2018 - 2030 (USD Million)
                   6.5. Biotechnology Applications
                       6.5.1. Biotechnology Applications Market, 2018 - 2030 (USD Million)
                   6.6. Food & Nutrition Applications
                       6.6.1. Food & Nutrition Applications Market, 2018 - 2030 (USD Million)
                   6.7. Others
                       6.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Workflow Business Analysis
                   7.1. Metagenomics market: Workflow Movement Analysis
                   7.2. Pre - sequencing
                       7.2.1. Pre - sequencing Market, 2018 - 2030 (USD Million)
                   7.3. Sequencing
                       7.3.1. Sequencing Market, 2018 - 2030 (USD Million)
                   7.4. Data Analysis
                       7.4.1. Data Analysis Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
                   8.1. Metagenomics market Share By Region, 2022 & 2030
                   8.2. North America
                       8.2.1. SWOT Analysis
                       8.2.2. North America Metagenomics market, 2018 - 2030 (USD Million)
                       8.2.3. U.S.
                           8.2.3.1. Key Country Dynamics
                           8.2.3.2. Competitive Scenario
                           8.2.3.3. Regulatory Framework
                           8.2.3.4. Target Disease Prevalence
                           8.2.3.5. U.S. Metagenomics market, 2018 - 2030 (USD Million)
                       8.2.4. Canada
                           8.2.4.1. Key Country Dynamics
                           8.2.4.2. Competitive Scenario
                           8.2.4.3. Regulatory Framework
                           8.2.4.4. Target Disease Prevalence
                           8.2.4.5. Canada Metagenomics market, 2018 - 2030 (USD Million)
                   8.3. Europe
                       8.3.1. SWOT Analysis
                       8.3.2. Europe Metagenomics market, 2018 - 2030 (USD Million)
                       8.3.3. Germany
                           8.3.3.1. Key Country Dynamics
                           8.3.3.2. Competitive Scenario
                           8.3.3.3. Regulatory Framework
                           8.3.3.4. Target Disease Prevalence
                           8.3.3.5. Germany Metagenomics market, 2018 - 2030 (USD Million)
                       8.3.4. UK
                           8.3.4.1. Key Country Dynamics
                           8.3.4.2. Competitive Scenario
                           8.3.4.3. Regulatory Framework
                           8.3.4.4. Target Disease Prevalence
                           8.3.4.5. UK Metagenomics market, 2018 - 2030 (USD Million)
                       8.3.5. France
                           8.3.5.1. Key Country Dynamics
                           8.3.5.2. Competitive Scenario
                           8.3.5.3. Regulatory Framework
                           8.3.5.4. Target Disease Prevalence
                           8.3.5.5. France Metagenomics market, 2018 - 2030 (USD Million)
                       8.3.6. Italy
                           8.3.6.1. Key Country Dynamics
                           8.3.6.2. Competitive Scenario
                           8.3.6.3. Regulatory Framework
                           8.3.6.4. Target Disease Prevalence
                           8.3.6.5. Italy Metagenomics market, 2018 - 2030 (USD Million)
                       8.3.7. Spain
                           8.3.7.1. Key Country Dynamics
                           8.3.7.2. Competitive Scenario
                           8.3.7.3. Regulatory Framework
                           8.3.7.4. Target Disease Prevalence
                           8.3.7.5. Spain Metagenomics market, 2018 - 2030 (USD Million)
                       8.3.8. Denmark
                           8.3.8.1. Key Country Dynamics
                           8.3.8.2. Competitive Scenario
                           8.3.8.3. Regulatory Framework
                           8.3.8.4. Target Disease Prevalence
                           8.3.8.5. Denmark Metagenomics market, 2018 - 2030 (USD Million)
                       8.3.9. Sweden
                           8.3.9.1. Key Country Dynamics
                           8.3.9.2. Competitive Scenario
                           8.3.9.3. Regulatory Framework
                           8.3.9.4. Target Disease Prevalence
                           8.3.9.5. Sweden Metagenomics market, 2018 - 2030 (USD Million)
                       8.3.10. Norway
                           8.3.10.1. Key Country Dynamics
                           8.3.10.2. Competitive Scenario
                           8.3.10.3. Regulatory Framework
                           8.3.10.4. Target Disease Prevalence
                           8.3.10.5. Norway Metagenomics market, 2018 - 2030 (USD Million)
                   8.4. Asia Pacific
                       8.4.1. SWOT Analysis
                       8.4.2. Asia Pacific Metagenomics market, 2018 - 2030 (USD Million)
                       8.4.3. Japan
                           8.4.3.1. Key Country Dynamics
                           8.4.3.2. Competitive Scenario
                           8.4.3.3. Regulatory Framework
                           8.4.3.4. Target Disease Prevalence
                           8.4.3.5. Japan Metagenomics market, 2018 - 2030 (USD Million)
                       8.4.4. China
                           8.4.4.1. Key Country Dynamics
                           8.4.4.2. Competitive Scenario
                           8.4.4.3. Regulatory Framework
                           8.4.4.4. Target Disease Prevalence
                           8.4.4.5. China Metagenomics market, 2018 - 2030 (USD Million)
                       8.4.5. India
                           8.4.5.1. Key Country Dynamics
                           8.4.5.2. Competitive Scenario
                           8.4.5.3. Regulatory Framework
                           8.4.5.4. Target Disease Prevalence
                           8.4.5.5. India Metagenomics market, 2018 - 2030 (USD Million)
                       8.4.6. South Korea
                           8.4.6.1. Key Country Dynamics
                           8.4.6.2. Competitive Scenario
                           8.4.6.3. Regulatory Framework
                           8.4.6.4. Target Disease Prevalence
                           8.4.6.5. South Korea Metagenomics market, 2018 - 2030 (USD Million)
                       8.4.7. Australia
                           8.4.7.1. Key Country Dynamics
                           8.4.7.2. Competitive Scenario
                           8.4.7.3. Regulatory Framework
                           8.4.7.4. Target Disease Prevalence
                           8.4.7.5. Australia Metagenomics market, 2018 - 2030 (USD Million)
                       8.4.8. Thailand
                           8.4.8.1. Key Country Dynamics
                           8.4.8.2. Competitive Scenario
                           8.4.8.3. Regulatory Framework
                           8.4.8.4. Target Disease Prevalence
                           8.4.8.5. Thailand Metagenomics market, 2018 - 2030 (USD Million)
                   8.5. Latin America
                       8.5.1. SWOT Analysis
                       8.5.2. Latin America Metagenomics market, 2018 - 2030 (USD Million)
                       8.5.3. Brazil
                           8.5.3.1. Key Country Dynamics
                           8.5.3.2. Competitive Scenario
                           8.5.3.3. Regulatory Framework
                           8.5.3.4. Target Disease Prevalence
                           8.5.3.5. Brazil Metagenomics market, 2018 - 2030 (USD Million)
                       8.5.4. Mexico
                           8.5.4.1. Key Country Dynamics
                           8.5.4.2. Competitive Scenario
                           8.5.4.3. Regulatory Framework
                           8.5.4.4. Target Disease Prevalence
                           8.5.4.5. Mexico Metagenomics market, 2018 - 2030 (USD Million)
                       8.5.5. Argentina
                           8.5.5.1. Key Country Dynamics
                           8.5.5.2. Competitive Scenario
                           8.5.5.3. Regulatory Framework
                           8.5.5.4. Target Disease Prevalence
                           8.5.5.5. Argentina Metagenomics market, 2018 - 2030 (USD Million)
                   8.6. MEA
                       8.6.1. SWOT Analysis
                       8.6.2. MEA Metagenomics market, 2018 - 2030 (USD Million)
                       8.6.3. South Africa
                           8.6.3.1. Key Country Dynamics
                           8.6.3.2. Competitive Scenario
                           8.6.3.3. Regulatory Framework
                           8.6.3.4. Target Disease Prevalence
                           8.6.3.5. South Africa Metagenomics market, 2018 - 2030 (USD Million)
                       8.6.4. Saudi Arabia
                           8.6.4.1. Key Country Dynamics
                           8.6.4.2. Competitive Scenario
                           8.6.4.3. Regulatory Framework
                           8.6.4.4. Target Disease Prevalence
                           8.6.4.5. Saudi Arabia Metagenomics market, 2018 - 2030 (USD Million)
                       8.6.5. UAE
                           8.6.5.1. Key Country Dynamics
                           8.6.5.2. Competitive Scenario
                           8.6.5.3. Regulatory Framework
                           8.6.5.4. Target Disease Prevalence
                           8.6.5.5. UAE Metagenomics market, 2018 - 2030 (USD Million)
                       8.6.6. Kuwait
                           8.6.6.1. Key Country Dynamics
                           8.6.6.2. Competitive Scenario
                           8.6.6.3. Regulatory Framework
                           8.6.6.4. Target Disease Prevalence
                           8.6.6.5. Kuwait Metagenomics market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
                   9.1. Company Categorization
                   9.2. Strategy Mapping
                   9.3. Company Profiles/Listing
                       9.3.1. Illumina, Inc.
                           9.3.1.1. Overview
                           9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.1.3. Product Benchmarking
                           9.3.1.4. Strategic Initiatives
                       9.3.2. Thermo Fisher Scientific, Inc.
                           9.3.2.1. Overview
                           9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.2.3. Product Benchmarking
                           9.3.2.4. Strategic Initiatives
                       9.3.3. Bio - Rad Laboratories, Inc..
                           9.3.3.1. Overview
                           9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.3.3. Product Benchmarking
                           9.3.3.4. Strategic Initiatives
                       9.3.4. PerkinElmer, Inc.
                           9.3.4.1. Overview
                           9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.4.3. Product Benchmarking
                           9.3.4.4. Strategic Initiatives
                       9.3.5. Promega Corporation
                           9.3.5.1. Overview
                           9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.5.3. Product Benchmarking
                           9.3.5.4. Strategic Initiatives
                       9.3.6. Oxford Nanopore Technologies
                           9.3.6.1. Overview
                           9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.6.3. Product Benchmarking
                           9.3.6.4. Strategic Initiatives
                       9.3.7. Qiagen
                           9.3.7.1. Overview
                           9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.7.3. Product Benchmarking
                           9.3.7.4. Strategic Initiatives
                       9.3.8. Takara Bio, Inc.
                           9.3.8.1. Overview
                           9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.8.3. Product Benchmarking
                           9.3.8.4. Strategic Initiatives
                       9.3.9. Novogene Co., Ltd.
                           9.3.9.1. Overview
                           9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.9.3. Product Benchmarking
                           9.3.9.4. Strategic Initiatives
                       9.3.10. F. Hoffmann - La Roche Ltd.
                           9.3.10.1. Overview
                           9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           9.3.10.3. Product Benchmarking
                           9.3.10.4. Strategic Initiatives


List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 4 Global Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 5 Global Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 6 Global Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 7 Global Metagenomics Market, by Region, 2018 - 2030 (USD Million)
Table 8 North America Metagenomics Market, by Country, 2018 - 2030 (USD Million)
Table 9 North America Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 10 North America Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 11 North America Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 12 North America Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 13 U.S. Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 14 U.S. Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 15 U.S. Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 16 U.S. Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 17 Canada Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 18 Canada Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 19 Canada Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 20 Canada Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 21 Europe Metagenomics Market, by Country, 2018 - 2030 (USD Million)
Table 22 Europe Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 23 Europe Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 24 Europe Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 25 Europe Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 26 Germany Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 27 Germany Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 28 Germany Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 29 Germany Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 30 UK Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 31 UK Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 32 UK Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 33 UK Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 34 France Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 35 France Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 36 France Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 37 France Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 38 Italy Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 39 Italy Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 40 Italy Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 41 Italy Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 42 Spain Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 43 Spain Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 44 Spain Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 45 Spain Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 46 Denmark Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 47 Denmark Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 48 Denmark Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 49 Denmark Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 50 Norway Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 51 Norway Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 52 Norway Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 53 Norway Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 54 Sweden Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 55 Sweden Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 56 Sweden Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 57 Sweden Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Metagenomics Market, by Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 63 China Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 64 China Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 65 China Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 66 China Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 67 Japan Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 68 Japan Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 69 Japan Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 70 Japan Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 71 India Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 72 India Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 73 India Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 74 India Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 75 South Korea Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 76 South Korea Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 77 South Korea Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 78 South Korea Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 79 Australia Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 80 Australia Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 81 Australia Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 82 Australia Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 83 Latin America Metagenomics Market, by Country, 2018 - 2030 (USD Million)
Table 84 Thailand Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 85 Thailand Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 86 Thailand Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 87 Thailand Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 88 Latin America Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 89 Latin America Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 90 Latin America Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 91 Latin America Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 92 Brazil Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 93 Brazil Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 94 Brazil Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 95 Brazil Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 96 Mexico Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 97 Mexico Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 98 Mexico Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 99 Mexico Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 100 Argentina Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 101 Argentina Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 102 Argentina Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 103 Argentina Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Metagenomics Market, by Country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 109 South Africa Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 110 South Africa Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 111 South Africa Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 112 South Africa Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 116 Saudi Arabia Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 117 UAE Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 118 UAE Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 119 UAE Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 120 UAE Metagenomics Market, Workflow, 2018 - 2030 (USD Million)
Table 121 Kuwait Metagenomics Market, by Technology, 2018 - 2030 (USD Million)
Table 122 Kuwait Metagenomics Market, by Product, 2018 - 2030 (USD Million)
Table 123 Kuwait Metagenomics Market, by Application, 2018 - 2030 (USD Million)
Table 124 Kuwait Metagenomics Market, Workflow, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain - Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Metagenomics, Market Segmentation
Fig. 8 Market Snapshot, 2021
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
Fig. 16 Global Metagenomics Market: Technology Movement Analysis
Fig. 17 Global Metagenomics Market, for Shotgun Sequencing, 2018 - 2030 (USD Million)
Fig. 18 Global Metagenomics Market, for 16S Sequencing, 2018 - 2030 (USD Million)
Fig. 19 Global Metagenomics Market, for Whole Genome Sequencing, 2018 - 2030 (USD Million)
Fig. 20 Global Metagenomics Market, for Others, 2018 - 2030 (USD Million)
Fig. 21 Global Metagenomics Market: Product Movement Analysis
Fig. 22 Global Metagenomics Market, for Kits & Reagents, 2018 - 2030 (USD Million)
Fig. 23 Global Metagenomics Market, for Sequencing & Data Analytics Services, 2018 - 2030 (USD Million)
Fig. 24 Global Metagenomics Market, for Software, 2018 - 2030 (USD Million)
Fig. 25 Global Metagenomics Market: Application Movement Analysis
Fig. 26 Global Metagenomics Market, for Environmental, 2018 - 2030 (USD Million)
Fig. 27 Global Metagenomics Market, for Clinical Diagnostics, 2018 - 2030 (USD Million)
Fig. 28 Global Metagenomics Market, for Drug Discovery, 2018 - 2030 (USD Million)
Fig. 29 Global Metagenomics Market, for Biotechnology, 2018 - 2030 (USD Million)
Fig. 30 Global Metagenomics Market, for Food & Nutrition, 2018 - 2030 (USD Million)
Fig. 31 Global Metagenomics Market, for Others, 2018 - 2030 (USD Million)
Fig. 32 Global Metagenomics Market: Workflow Movement Analysis
Fig. 33 Global Metagenomics Market, for Pre - sequencing, 2018 - 2030 (USD Million)
Fig. 34 Global Metagenomics Market, for Sequencing, 2018 - 2030 (USD Million)
Fig. 35 Global Metagenomics Market, for Data Analysis, 2018 - 2030 (USD Million)
Fig. 36 Regional Marketplace: Key Takeaways
Fig. 37 Regional Outlook, 2021 & 2030
Fig. 38 Global Metagenomics Market: Region Movement Analysis
Fig. 39 North America Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 40 U.S. Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 41 Canada Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 42 Europe Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 43 Germany Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 44 UK Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 45 France Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 46 Italy Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 47 Spain Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 48 Denmark Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 49 Norway Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 50 Sweden Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 52 Japan Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 53 China Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 54 India Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 55 Thailand Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 56 Australia Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 57 South Korea Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 58 Latin America Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 59 Brazil Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 60 Mexico Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 61 Argentina Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 62 Middle East and Africa Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 63 South Africa Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 64 Saudi Arabia Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 65 UAE Metagenomics Market, 2018 - 2030 (USD Million)
Fig. 66 Kuwait Metagenomics Market, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon